Suppr超能文献

一项基于人群的队列研究,旨在阐明精神分裂症与代谢综合征之间的时间关系(KCIS 编号 PSY3)。

A population-based cohort study to elucidate temporal relationship between schizophrenia and metabolic syndrome (KCIS no. PSY3).

机构信息

Department of Nursing, College of Medicine, National Taiwan University, Taipei, Taiwan; National Taiwan University Hospital, Taipei, Taiwan.

出版信息

Schizophr Res. 2013 Dec;151(1-3):158-64. doi: 10.1016/j.schres.2013.09.017. Epub 2013 Oct 6.

Abstract

BACKGROUND

The bidirectional relationships between metabolic syndrome (MetS) and schizophrenia (SCZ) play a crucial role in clinical treatment of both diseases but such bidirectional causal effects have not been comprehensively elucidated.

AIMS

To investigate the influence of MetS on incident SCZ and the opposite direction as well as their predictors for each direction with a population-based cohort sample.

METHOD

We enrolled 76,545 subjects who had participated in a community-based health screening program during 1999-2004. After excluding those with the existing MetS or SCZ at baseline, the two normal prospective cohorts corresponding to each independent variable of MetS or SCZ, respectively, were followed over time to ascertain incident outcome of SCZ and MetS. The crude and adjusted hazard ratios for the effect of the predictor on each incident outcome were estimated after controlling for the possible confounding factors.

RESULTS

The overall incidence rate (per 10(5)person-years) of SCZ was 61.15. The incidence rate in patients with MetS was lower than those without (44.24 versus 64.20), indicating the presence of MetS failed to find an increased risk of developing incident SCZ. However, participants with abnormal waist circumference (WC) were two times (95% CI: 1.37 to 2.93) more likely to yield incident SCZ compared to those with normal WC. In the opposite direction, the incidence of MetS was statistically higher in patients with SCZ than those without SCZ (11.25% vs 7.94%, respectively), suggesting SCZ conferred a higher risk for yielding incident MetS (adjusted hazard ratio=1.89, 95% CI: 1.36, 2.63).

CONCLUSIONS

After examining the bidirectional causal relationships between SCZ and MetS with the theoretically sound and large population-based prospective cohort study, central obesity, one of the individual components of MetS, was corroborated as an independent predictor for incident SCZ. Patients diagnosed with SCZ were at greater risk of having incident cases of MetS. Such significant temporal bidirectional relationships between SCZ and central obesity suggest a reciprocal interaction exits between SCZ and central obesity.

摘要

背景

代谢综合征(MetS)和精神分裂症(SCZ)之间的双向关系在这两种疾病的临床治疗中起着至关重要的作用,但这种双向因果关系尚未得到全面阐明。

目的

使用基于人群的队列样本,研究代谢综合征对精神分裂症发病的影响,以及相反方向的影响,并探讨其各自方向的预测因素。

方法

我们纳入了 76545 名参加了 1999-2004 年社区健康筛查项目的受试者。在排除基线时已存在代谢综合征或精神分裂症的患者后,分别对每个代谢综合征或精神分裂症独立变量对应的两个正常前瞻性队列进行随访,以确定精神分裂症和代谢综合征的发病结果。在控制可能的混杂因素后,估计预测因素对每种发病结果的影响的未调整和调整后的危险比。

结果

精神分裂症的总发病率(每 105 人年)为 61.15。患有代谢综合征的患者的发病率低于未患有代谢综合征的患者(44.24 与 64.20),这表明存在代谢综合征并不能发现发生精神分裂症的风险增加。然而,与正常腰围(WC)的参与者相比,腰围异常的参与者发生精神分裂症的风险高出两倍(95%CI:1.37 至 2.93)。在相反的方向上,患有精神分裂症的患者的代谢综合征发病率明显高于没有精神分裂症的患者(分别为 11.25%和 7.94%),这表明精神分裂症使发生代谢综合征的风险更高(调整后的危险比=1.89,95%CI:1.36,2.63)。

结论

通过使用理论上合理且基于人群的大型前瞻性队列研究来检验精神分裂症和代谢综合征之间的双向因果关系,代谢综合征的一个个体成分——中心性肥胖,被证实为精神分裂症发病的独立预测因素。诊断为精神分裂症的患者发生代谢综合征的风险更高。精神分裂症和中心性肥胖之间存在这种显著的时间双向关系表明,精神分裂症和中心性肥胖之间存在相互作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验